Dentsply Sirona downgraded at Leerink after guidance cut

seekingalpha11-08

aluxum/E+ via Getty ImagesWith its Q3 2024 financials on Thursday, Dentsply Sirona (NASDAQ:XRAY) met Street forecasts but slashed its full-year outlook, prompting Leerink Partners to downgrade the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481364851?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185108607/image_185108607.jpg?io=getty-c-w750","is_english":true,"pubTime":"2024-11-08 01:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481364851","market":"other","top_or_hot":-1,"title":"Dentsply Sirona downgraded at Leerink after guidance cut","media":"seekingalpha","content":"<div>\n<p>aluxum/E+ via Getty ImagesWith its Q3 2024 financials on Thursday, Dentsply Sirona (NASDAQ:XRAY) met Street forecasts but slashed its full-year outlook, prompting Leerink Partners to downgrade the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4261849-dentsply-sirona-stock-downgraded-leerink\">Source Link</a>\n\n</div>\n","source":"seekingalpha_trending_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dentsply Sirona downgraded at Leerink after guidance cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDentsply Sirona downgraded at Leerink after guidance cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-08 01:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4261849-dentsply-sirona-stock-downgraded-leerink><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>aluxum/E+ via Getty ImagesWith its Q3 2024 financials on Thursday, Dentsply Sirona (NASDAQ:XRAY) met Street forecasts but slashed its full-year outlook, prompting Leerink Partners to downgrade the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4261849-dentsply-sirona-stock-downgraded-leerink\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XRAY","symbol_name":"登士柏国际","start_time":0,"source_url":"https://seekingalpha.com/news/4261849-dentsply-sirona-stock-downgraded-leerink","article_id":"2481364851","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/185108607/image_185108607.jpg?io=getty-c-w750"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481364851","pubTimestamp":1730999464,"sourceInfo":{"source_id":"seekingalpha_trending_news","name":"Seeking Alpha Trending News"},"weMediaInfo":null,"summary":"aluxum/E+ via Getty ImagesWith its Q3 2024 financials on Thursday, Dentsply Sirona  met Street forecasts but slashed its full-year outlook, prompting Leerink Partners to downgrade the dental care company to Market Perform from Outperform. Dentsply  lowered its 2024 organic sales growth outlook to  to  from (1%) to flat previously and updated its outlook for adj. earnings per share to $1.82-$1.86 from $1.96-$2.02, which fell short of $1.98 in the consensus. The Charlotte, North Carolina-based company cited ongoing U.S. market pressures and its decision to suspend sales of its Byte Aligners as reasons for the revised growth outlook. \"With ongoing growth challenges, the Byte suspension , and what remains a choppy market, we find it hard to remain constructive until we see better data points,\" Leerink wrote. The brokerage trimmed its price target on XRAY to $21 from $32 per share after revising the stock's 2025 EV/EBITDA multiple to ~8.5x from ~10x, citing uncertainty over the company's re","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"XRAY":"登士柏国际"},"translate_title":"Dentsply Sirona在指引下调后下调Leerink评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XRAY":1},"content_text":"aluxum/E+ via Getty ImagesWith its Q3 2024 financials on Thursday, Dentsply Sirona (NASDAQ:XRAY) met Street forecasts but slashed its full-year outlook, prompting Leerink Partners to downgrade the dental care company to Market Perform from Outperform. Dentsply (NASDAQ:XRAY) lowered its 2024 organic sales growth outlook to (3.5%) to (2.5%) from (1%) to flat previously and updated its outlook for adj. earnings per share to $1.82-$1.86 from $1.96-$2.02, which fell short of $1.98 in the consensus. The Charlotte, North Carolina-based company cited ongoing U.S. market pressures and its decision to suspend sales of its Byte Aligners as reasons for the revised growth outlook. \"With ongoing growth challenges, the Byte suspension (we have removed Byte from our model for now), and what remains a choppy market, we find it hard to remain constructive until we see better data points,\" Leerink wrote. The brokerage trimmed its price target on XRAY to $21 from $32 per share after revising the stock's 2025 EV/EBITDA multiple to ~8.5x from ~10x, citing uncertainty over the company's revenue growth and other factors.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481364851"}